ASIA PACIFIC CONTRACEPTIVE MARKET FORECAST 2019-2027
Asia Pacific Contraceptive Market by Education (Less Than High School, High School Graduate, College Graduate, Other College Degrees) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End-user (Households, Clinics, Hospitals) by Drugs and Devices (Contraceptives Drugs, Contraceptive Devices) by Geography.
The contraceptives are available in the form of devices or medication drugs for inhibiting pregnancy, the transmission of sexually transmitted infections, and birth control & family planning. Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life.
The Asia Pacific contraceptive market is estimated to grow from $XX billion in 2018 to $XX billion by 2027, at a CAGR of 7.67% during the forecasting years of 2019-2027.
The use of advanced contraceptive methods and emergency contraceptives method, especially for teenagers and increase in awareness regarding sexually transmitted infections (STIs), are the major factors responsible for the growth of the contraceptives market. The economies of China, India, Japan, South Korea, Australia and the remaining countries collectively forming the Rest of Asia Pacific are the major influencers of the APAC contraceptive market. For decades, female sterilization has been the most popular form of contraception in India, and it remains so today. It is one of the reasons why the country is expected to have the fastest growth rate by the end of the forecasting period.
The Asia-Pacific contraceptives market is on a continuous rise due to the increase in the need for contraceptives in developing economies. The main challenge that has been reported in this region is providing sexual health information & services to an inappropriate population. Several initiatives are taken by the government to help increase awareness among the population, and coupled with the open conferences organized by them are the major factors that drive the market growth.
Bayer AG, Teva Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Okamoto Industries, Inc., OCON Medical Ltd., Afaxys, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Pfizer, Inc., Church & Dwight Co., Inc., Cooper Surgical Inc., Allergan Inc., Reckitt Benckiser PLC, Agile Therapeutics, and Pregna are the major companies that are mentioned in the report.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- COLLEGE GRADUATE HOLDS THE LARGEST MARKET SHARE IN TERMS OF EDUCATION
- AGE GROUP OF 15–24 YEARS IS ANTICIPATED TO GROW SIGNIFICANTLY
- HOUSEHOLDS ARE THE MAJOR END-USER
- CONTRACEPTIVES DEVICES ARE WIDELY USED
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- RISING CUSTOMER AWARENESS AND GOVERNMENT INITIATIVES
- GROWING INCIDENCE OF UNWANTED PREGNANCIES
- OCCURRENCE OF SEXUALLY TRANSMITTED DISEASES (STD)
- MARKET RESTRAINTS
- INCREASING AGING POPULATION
- SIDE EFFECTS ASSOCIATED WITH THE USE OF CONTRACEPTIVE DRUGS AND DEVICES
- MARKET OPPORTUNITIES
- INCREASE IN AWARENESS AND IMPORTANCE REGARDING FAMILY PLANNING
- STRATEGIC ALLIANCES AND INVESTING IN R&D
- MARKET CHALLENGES
- LACK OF PERCEPTION OF SOCIETY
- INCREASING COST AND INACCESSIBILITY OF CERTAIN HEALTH SERVICES
- MARKET BY EDUCATION
- LESS THAN HIGH SCHOOL
- HIGH SCHOOL GRADUATE
- COLLEGE GRADUATE
- OTHER COLLEGE DEGREES
- MARKET BY AGE GROUP
- 15–24 YEARS
- 25–34 YEARS
- 35–44 YEARS
- ABOVE 44 YEARS
- MARKET BY END-USER
- HOUSEHOLDS
- CLINICS
- HOSPITALS
- MARKET BY DRUGS AND DEVICES
- CONTRACEPTIVES DRUGS
- ORAL CONTRACEPTIVE PILLS
- INJECTABLE CONTRACEPTIVES
- TOPICAL CONTRACEPTIVES
- CONTRACEPTIVE DEVICES
- MALE CONDOMS
- FEMALE CONDOMS
- DIAPHRAGMS
- CONTRACEPTIVE SPONGES
- VAGINAL RINGS
- SUBDERMAL IMPLANTS
- INTRA-UTERINE DEVICES
- COPPER INTRA-UTERINE DEVICES
- HORMONAL INTRA-UTERINE DEVICES
- CONTRACEPTIVES DRUGS
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- PESTEL ANALYSIS
- MARKET TRENDS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- AFAXYS, INC.
- AGILE THERAPEUTICS
- ALLERGAN INC.
- APOTHECUS PHARMACEUTICAL CORPORATION
- BAYER AG
- CHURCH & DWIGHT CO., INC.
- COOPER SURGICAL INC.
- MAYER LABORATORIES, INC.
- MERCK & CO., INC.
- OCON MEDICAL LTD.
- OKAMOTO INDUSTRIES, INC.
- PFIZER, INC.
- PREGNA
- RECKITT BENCKISER PLC
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
TABLE LIST
TABLE 1 ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
TABLE 2 ASSOCIATED SIDE EFFECTS FOR DIFFERENT CONTRACEPTIVE METHOD
TABLE 3 ASIA PACIFIC CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC LESS THAN HIGH SCHOOL MARKET BY 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC HIGH SCHOOL GRADUATE MARKET BY 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC COLLEGE GRADUATE MARKET BY 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC OTHER COLLEGE DEGREES MARKET BY 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC 15–24 YEARS MARKET BY 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC 25–34 YEARS MARKET BY 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC 35–44 YEARS MARKET BY 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC ABOVE 44 YEARS MARKET BY 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC CONTRACEPTIVE MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC HOUSEHOLDS MARKET BY 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC CLINICS MARKET BY 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC HOSPITALS MARKET BY 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC ORAL CONTRACEPTIVE PILLS MARKET BY 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC INJECTABLE CONTRACEPTIVES MARKET BY 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC TOPICAL CONTRACEPTIVES MARKET BY 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC MALE CONDOMS MARKET BY 2019-2027 ($ MILLION)
TABLE 26 ASIA PACIFIC FEMALE CONDOMS MARKET BY 2019-2027 ($ MILLION)
TABLE 27 ASIA PACIFIC DIAPHRAGMS MARKET BY 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC CONTRACEPTIVE SPONGES MARKET BY 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC VAGINAL RINGS MARKET BY 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC SUBDERMAL IMPLANTS MARKET BY 2019-2027 ($ MILLION)
TABLE 31 ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)
TABLE 32 ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 33 ASIA PACIFIC COPPER INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)
TABLE 34 ASIA PACIFIC HORMONAL INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)
TABLE 35 ASIA PACIFIC CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 36 JAPAN CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 37 CHINA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 38 INDIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 39 AUSTRALIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 40 SOUTH KOREA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
FIGURE LIST
FIGURE 1 ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY EDUCATION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY AGE GROUP 2018 & 2027 (%)
FIGURE 8 ASIA PACIFIC CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 13 ASIA PACIFIC CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY DRUGS AND DEVICES 2018 & 2027 (%)
FIGURE 17 ASIA PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 28 ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 29 ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 30 ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 31 PORTER’S FIVE FORCE MODEL
FIGURE 32 JAPAN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 33 CHINA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 34 INDIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 35 AUSTRALIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 36 SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
FIGURE 37 REST OF ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- MARKET BY EDUCATION
- LESS THAN HIGH SCHOOL
- HIGH SCHOOL GRADUATE
- COLLEGE GRADUATE
- OTHER COLLEGE DEGREES
- MARKET BY AGE GROUP
- 15–24 YEARS
- 25–34 YEARS
- 35–44 YEARS
- ABOVE 44 YEARS
- MARKET BY END-USER
- HOUSEHOLDS
- CLINICS
- HOSPITALS
- MARKET BY DRUGS AND DEVICES
- CONTRACEPTIVES DRUGS
- ORAL CONTRACEPTIVE PILLS
- INJECTABLE CONTRACEPTIVES
- TOPICAL CONTRACEPTIVES
- CONTRACEPTIVE DEVICES
- MALE CONDOMS
- FEMALE CONDOMS
- DIAPHRAGMS
- CONTRACEPTIVE SPONGES
- VAGINAL RINGS
- SUBDERMAL IMPLANTS
- INTRA-UTERINE DEVICES
- COPPER INTRA-UTERINE DEVICES
- HORMONAL INTRA-UTERINE DEVICES
- CONTRACEPTIVES DRUGS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.